[ 1] G rignan i F, Fag io liM, A lca layM, et a ,l Acute prom ye locy tic leukem ia: from genetics to treatm ent [ J] . B lood, 1994, 83
( 1): 10-25.
[ 2] Sa lomon i P, Ferguson B J, W y llie A H, et a.l New insights into the ro le o f PML in tum our suppression [ J]. Ce ll Res,
2008, 18( 6): 622-640.
[ 3] Z imberA, Nguyen Q D, Gespach C. Nuclear bod ies and com pa rtm en ts: func tiona l ro les and ce llu lar s igna lling in hea lth and
d isease [ J]. Ce ll S igna,l 2004, 16( 10): 1 085-1 104.
[ 4] Jensen K, Sh ie ls C, Freement P S, e t a.l PML prote in isform s and the RBCC /TRIM m otif [ J]. Oncogene, 2001, 20( 49):
7 223-7 233
[ 5] BernardiR, PapaA, Pando lfiPP. Regu la tion o f apoptosis by PML and the PML-NB s[ J]. Oncogene, 2008, 27( 48): 6 299-
6 312.
[ 6] Fag io liM, A lca layM, Pando lfi P P, e t a.l Alternative splic ing of PML transcr ipts predicts coexpression of several carboxyterm
inally d ifferent protein iso fo rm s [ J]. Oncogene, 1992, 7( 6): 1 083-1 091.
[ 7] Liu JH, L iu C C, Yen C C, e t a.l Pm l and TAp73 interacting a t nuclear body m ed ia te im atin ib- induced p53- independent
apoptos is of chron ic mye lo id leukem ia ce lls [ J] . Int J Cancer, 2009, 125( 1): 71-77
[ 8] X iaM, Zhang J Q, Shen Y Q, et a .l Concordan t expression o f proto-oncogene promye lo cy tic leukem ia and m ajor histocompatib
ility antig en H LA c lass I in hum an hepatocellu lar carc inom a [ J]. T issue Antigens, 2007, 70( 4): 272-282.
[ 9] WuW S, V allian S, Seto E, et a.l The grow th suppressor PML represses transcription by func tiona lly and physically interacting
w ith h istone deace tylases [ J]. M o l Ce ll B io,l 2001, 21( 7): 2 259-2 268.
[ 10] M atsush itaH, Scag lioni P P, Bhaum ikM, et a .l In v ivo ana ly sis of the ro le o f aberrant h istone deacety lase recruitm ent and
RAR alpha b lo ckade in the pa thogenesis o f acute prom yelocytic leukem ia [ J]. J ExpM ed, 2006, 203( 4): 821-828.